2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Tumor Immunology
Tumor immunology explores the intricate relationship between cancer cells and the immune system. It delves into understanding how cancer cells evade immune detection and how the immune system can be harnessed to recognize and destroy tumors. Key areas of study include tumor antigens, immune checkpoint pathways, and immunotherapies. By identifying specific antigens expressed by tumors, researchers aim to develop targeted therapies that enhance immune recognition of cancer cells. Immune checkpoint inhibitors, such as PD-1 and CTLA-4 blockers, unleash the immune system's ability to attack tumors. Additionally, adoptive cell therapies, like CAR-T cells, genetically engineer immune cells to better recognize and kill cancer. Advancements in tumor immunology hold promise for more effective and personalized cancer treatments, offering hope for improved outcomes and quality of life for patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China